Clarithromycin prevents preterm birth and neonatal mortality by dampening alarmin-induced maternal–fetal inflammation in mice
dc.contributor.author | Galaz, Jose | |
dc.contributor.author | Romero, Roberto | |
dc.contributor.author | Arenas-Hernandez, Marcia | |
dc.contributor.author | Farias-Jofre, Marcelo | |
dc.contributor.author | Motomura, Kenichiro | |
dc.contributor.author | Liu, Zhenjie | |
dc.contributor.author | Kawahara, Naoki | |
dc.contributor.author | Demery-Poulos, Catherine | |
dc.contributor.author | Liu, Tzu N. | |
dc.contributor.author | Padron, Justin | |
dc.contributor.author | Panaitescu, Bogdan | |
dc.contributor.author | Gomez-Lopez, Nardhy | |
dc.date.accessioned | 2022-08-10T18:19:27Z | |
dc.date.available | 2022-08-10T18:19:27Z | |
dc.date.issued | 2022-06-20 | |
dc.identifier.citation | BMC Pregnancy and Childbirth. 2022 Jun 20;22(1):503 | |
dc.identifier.uri | https://doi.org/10.1186/s12884-022-04764-2 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/173661 | en |
dc.description.abstract | Abstract Background One of every four preterm neonates is born to a woman with sterile intra-amniotic inflammation (inflammatory process induced by alarmins); yet, this clinical condition still lacks treatment. Herein, we utilized an established murine model of sterile intra-amniotic inflammation induced by the alarmin high-mobility group box-1 (HMGB1) to evaluate whether treatment with clarithromycin prevents preterm birth and adverse neonatal outcomes by dampening maternal and fetal inflammatory responses. Methods Pregnant mice were intra-amniotically injected with HMGB1 under ultrasound guidance and treated with clarithromycin or vehicle control, and pregnancy and neonatal outcomes were recorded (n = 15 dams each). Additionally, amniotic fluid, placenta, uterine decidua, cervix, and fetal tissues were collected prior to preterm birth for determination of the inflammatory status (n = 7–8 dams each). Results Clarithromycin extended the gestational length, reduced the rate of preterm birth, and improved neonatal mortality induced by HMGB1. Clarithromycin prevented preterm birth by interfering with the common cascade of parturition as evidenced by dysregulated expression of contractility-associated proteins and inflammatory mediators in the intra-uterine tissues. Notably, clarithromycin improved neonatal survival by dampening inflammation in the placenta as well as in the fetal lung, intestine, liver, and spleen. Conclusions Clarithromycin prevents preterm birth and improves neonatal survival in an animal model of sterile intra-amniotic inflammation, demonstrating the potential utility of this macrolide for treating women with this clinical condition, which currently lacks a therapeutic intervention. | |
dc.title | Clarithromycin prevents preterm birth and neonatal mortality by dampening alarmin-induced maternal–fetal inflammation in mice | |
dc.type | Journal Article | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/173661/1/12884_2022_Article_4764.pdf | |
dc.identifier.doi | https://dx.doi.org/10.7302/5392 | |
dc.language.rfc3066 | en | |
dc.rights.holder | The Author(s) | |
dc.date.updated | 2022-08-10T18:19:26Z | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.